Report cover image

Cancer Gene Therapy Global Market Report 2025

Published Sep 30, 2025
Length 250 Pages
SKU # BRC20428462

Description

Cancer Gene Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cancer gene therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for cancer gene therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cancer gene therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Therapy: Gene Induced Immunotherapy; Oncolytic Virotherapy; Gene Transfer

2) By Indication: Large B-Cell Lymphoma; Multiple Myeloma; Acute Lymphoblastic Leukemia (ALL); Melanoma (lesions); Other Indications

3) By Vector Type: Lentivirus; RetroVirus And Gamma RetroVirus; Adeno-Associated Virus (AAV); Modified Herpes Simplex Virus; Adenovirus; Other Vector Types

4) By End-User: Hospitals; Research Institutes; Biopharma Companies; Diagnostic centers; Other End Users

Subsegments:

1) By Gene Induced Immunotherapy: CAR-T Cell Therapy; TCR (T-Cell Receptor) Therapy; Tumor-Infiltrating Lymphocyte (TIL) Therapy; Dendritic Cell-Based Gene Therapy; NK Cell Gene Therapy

2) By Oncolytic Virotherapy: Adenoviruses; Herpes Simplex Virus (HSV); Reovirus; Vaccinia Virus; Newcastle Disease Virus (NDV)

3) By Gene Transfer: Viral Gene Transfer; Non-Viral Gene Transfer

Companies Mentioned: Bristol Myers Company; Novartis AG; GSK plc.; Gilead Sciences Inc.; Amgen Inc.; Orchard Therapeutics Plc; Biogen Inc.; Sarepta Therapeutics Inc.; AGC Biologics; Adaptimmune Limited; Sibiono; Elevate Bio Inc.; Bluebird Bio Inc.; Uniqure N.V.; Shanghai Sunway Biotech Co. Ltd.; Anges Inc.; Gensight Biologics; Genelux Corporation; Cellectis; Abeona Therapeutics Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

250 Pages
1. Executive Summary
2. Cancer Gene Therapy Market Characteristics
3. Cancer Gene Therapy Market Trends And Strategies
4. Cancer Gene Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Cancer Gene Therapy Growth Analysis And Strategic Analysis Framework
5.1. Global Cancer Gene Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Cancer Gene Therapy Market Growth Rate Analysis
5.4. Global Cancer Gene Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Cancer Gene Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Cancer Gene Therapy Total Addressable Market (TAM)
6. Cancer Gene Therapy Market Segmentation
6.1. Global Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gene Induced Immunotherapy
Oncolytic Virotherapy
Gene Transfer
6.2. Global Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Large B-Cell Lymphoma
Multiple Myeloma
Acute Lymphoblastic Leukemia (ALL)
Melanoma
Other Indications
6.3. Global Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lentivirus
RetroVirus And Gamma RetroVirus
Adeno-Associated Virus (AAV)
Modified Herpes Simplex Virus
Adenovirus
Other Vector Types
6.4. Global Cancer Gene Therapy Market, Segmentation By End-User , Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Research Institutes
Biopharma Companies
Diagnostic Centers
Other End Users
6.5. Global Cancer Gene Therapy Market, Sub-Segmentation Of Gene Induced Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
CAR-T Cell Therapy
TCR (T-Cell Receptor) Therapy
Tumor-Infiltrating Lymphocyte (TIL) Therapy
Dendritic Cell-Based Gene Therapy
NK Cell Gene Therapy
6.6. Global Cancer Gene Therapy Market, Sub-Segmentation Of Oncolytic Virotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adenoviruses
Herpes Simplex Virus (HSV)
Reovirus
Vaccinia Virus
Newcastle Disease Virus (NDV)
6.7. Global Cancer Gene Therapy Market, Sub-Segmentation Of Gene Transfer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Viral Gene Transfer
Non-Viral Gene Transfer
7. Cancer Gene Therapy Market Regional And Country Analysis
7.1. Global Cancer Gene Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Cancer Gene Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Cancer Gene Therapy Market
8.1. Asia-Pacific Cancer Gene Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Cancer Gene Therapy Market
9.1. China Cancer Gene Therapy Market Overview
9.2. China Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Cancer Gene Therapy Market
10.1. India Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Cancer Gene Therapy Market
11.1. Japan Cancer Gene Therapy Market Overview
11.2. Japan Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Cancer Gene Therapy Market
12.1. Australia Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Cancer Gene Therapy Market
13.1. Indonesia Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Cancer Gene Therapy Market
14.1. South Korea Cancer Gene Therapy Market Overview
14.2. South Korea Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Cancer Gene Therapy Market
15.1. Western Europe Cancer Gene Therapy Market Overview
15.2. Western Europe Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Cancer Gene Therapy Market
16.1. UK Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Cancer Gene Therapy Market
17.1. Germany Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Cancer Gene Therapy Market
18.1. France Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Cancer Gene Therapy Market
19.1. Italy Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Cancer Gene Therapy Market
20.1. Spain Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Cancer Gene Therapy Market
21.1. Eastern Europe Cancer Gene Therapy Market Overview
21.2. Eastern Europe Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Cancer Gene Therapy Market
22.1. Russia Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Cancer Gene Therapy Market
23.1. North America Cancer Gene Therapy Market Overview
23.2. North America Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Cancer Gene Therapy Market
24.1. USA Cancer Gene Therapy Market Overview
24.2. USA Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Cancer Gene Therapy Market
25.1. Canada Cancer Gene Therapy Market Overview
25.2. Canada Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Cancer Gene Therapy Market
26.1. South America Cancer Gene Therapy Market Overview
26.2. South America Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Cancer Gene Therapy Market
27.1. Brazil Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Cancer Gene Therapy Market
28.1. Middle East Cancer Gene Therapy Market Overview
28.2. Middle East Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Cancer Gene Therapy Market
29.1. Africa Cancer Gene Therapy Market Overview
29.2. Africa Cancer Gene Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Cancer Gene Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Cancer Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Cancer Gene Therapy Market Competitive Landscape And Company Profiles
30.1. Cancer Gene Therapy Market Competitive Landscape
30.2. Cancer Gene Therapy Market Company Profiles
30.2.1. Bristol Myers Company Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.3. GSK plc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Cancer Gene Therapy Market Other Major And Innovative Companies
31.1. Orchard Therapeutics Plc
31.2. Biogen Inc.
31.3. Sarepta Therapeutics Inc.
31.4. AGC Biologics
31.5. Adaptimmune Limited
31.6. Sibiono
31.7. Elevate Bio Inc.
31.8. Bluebird Bio Inc.
31.9. Uniqure N.V.
31.10. Shanghai Sunway Biotech Co. Ltd.
31.11. Anges Inc.
31.12. Gensight Biologics
31.13. Genelux Corporation
31.14. Cellectis
31.15. Abeona Therapeutics Inc.
32. Global Cancer Gene Therapy Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Cancer Gene Therapy Market
34. Recent Developments In The Cancer Gene Therapy Market
35. Cancer Gene Therapy Market High Potential Countries, Segments and Strategies
35.1 Cancer Gene Therapy Market In 2029 - Countries Offering Most New Opportunities
35.2 Cancer Gene Therapy Market In 2029 - Segments Offering Most New Opportunities
35.3 Cancer Gene Therapy Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.